Drug Side Effects
Search
ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA
ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA
was reported 28 times
ENDOMETRIAL HYPERPLASIA WITH CELLULAR ATYPIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Melanocortin 4 Receptor Agonist [EPC]
1
0.0035
1
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]
1
0.0001
2
Antifibrinolytic Agent [EPC]
1
0.0001
3
Prostacyclin Receptor Agonist [EPC]
2
0.0001
4
Provitamin D2 Compound [EPC]
2
0.0001
5
Progesterone [EPC]
1
0.0000
6
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
1
0.0000
7
Estrogen [EPC]
7
0.0000
8
Sympathomimetic-like Agent [EPC]
1
0.0000
9
Interleukin-23 Antagonist [EPC]
3
0.0000
10
Interleukin-17A Antagonist [EPC]
1
0.0000
11
Polyene Antifungal [EPC]
1
0.0000
12
Progestin [EPC]
5
0.0000
13
Factor Xa Inhibitor [EPC]
4
0.0000
14
Integrin Receptor Antagonist [EPC]
1
0.0000
15
Purine Antimetabolite [EPC]
1
0.0000
16
Aromatase Inhibitor [EPC]
1
0.0000
17
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
18
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
19
Calcium [EPC]
1
0.0000
20
Proton Pump Inhibitor [EPC]
2
0.0000
21
Osmotic Laxative [EPC]
1
0.0000
22
GLP-1 Receptor Agonist [EPC]
1
0.0000
23
Loop Diuretic [EPC]
1
0.0000
24
Platelet Aggregation Inhibitor [EPC]
1
0.0000
25
Corticosteroid [EPC]
2
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
1
0.0000
27
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000